Clinical Validation and Implementation of a Measurable Residual Disease Assay for NPM1 in Acute Myeloid Leukemia by Error-Corrected Next-Generation Sequencing

ConclusionPerformance and clinical utility of theNPM1 MRD assay are established via both validation experiments and analyses of live performance over 1.5  years of routine clinical service.

Source: Molecular Diagnosis and Therapy - October 30, 2019 Category: Molecular Biology Source Type: research